PDF factsheet
      Z

renin inhibitor in hypertension for diabetic patients , clinical trials results

aliskiren versus placebo
AVOID, 2008
NCT00097955
aliskiren (150 mg daily for 3 months, followed by an increase in dosage to 300 mg daily for another 3 months
versus
placebo
patients with hypertension and type 2 diabetes with nephropathydouble blind
Follow-up duration: 6 months
15 countries

  Options


in first

in second

  Filter